Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cytophage Technologies Ltd
V.CYTO
Alternate Symbol(s):
CPTCF
Healthcare
Biotechnology
Cytophage Technologies Ltd. is a Canadian biotechnology company. The Company uses advanced molecular genetic techniques and synthetic biology to create bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals...
, and plants. To combat dangerous bacteria, the Company generates customized phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a phage-display methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is poultry health products offered by the Company.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CYTO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 04, 2024 7:50am
New Press Release - Cytophage CEO to Present at TEDx Winnipeg Event
(TheNewswire)Winnipeg, June 4, 2024. - TheNewswire - Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, is pleased to announce that its CEO Dr. Steven...
read article.
(998)
•••
a2bman
X
Comment by
a2bman
on May 30, 2024 9:59am
RE:RE:RE:Phages work
Oh ic. nice. buying the dips
(0)
•••
PressRelease
X
Post by
PressRelease
on May 30, 2024 7:50am
New Press Release - Cytophage Reports Q1 Financials and Provides Business Update
(TheNewswire)Winnipeg – TheNewswire - May 30, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, today announced that it has filed its financial...
read article.
(33)
•••
Speedmaster2022
X
Comment by
Speedmaster2022
on May 27, 2024 2:20pm
RE:RE:Phages work
Oviphage An application for regulatory approval in the United States has been submitted and a similar regulatory approval submission for Canada is currently being developed
(998)
•••
a2bman
X
Comment by
a2bman
on May 27, 2024 12:01pm
RE:Phages work
What us news, like a listing? a little small, no?
(0)
•••
PressRelease
X
Post by
PressRelease
on May 27, 2024 7:52am
New Press Release - Cytophage Strengthens Board of Directors
(TheNewswire)Winnipeg, May 27, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, is pleased to announce that it has strengthened its board of...
read article.
(33)
•••
Speedmaster2022
X
Post by
Speedmaster2022
on May 23, 2024 10:52pm
Phages work
This'll bust out on U.S. news.
(998)
•••
a2bman
X
Comment by
a2bman
on May 23, 2024 12:21pm
RE:Avian flu in cows milk
The Lancet Infectious Disease journal reported in its review of 59 clinical studies between 2000 and 2021, that of 1,904 patients with chronic and drug resistant infections treated with phages, 79
...more
(2113)
•••
lscfa
X
Post by
lscfa
on May 22, 2024 9:07am
Avian flu in cows milk
One more reason to use co's livestock product. https://www.cbsnews.com/news/bird-flu-raw-milk-unpasteurized-dairy/
(998)
•••
a2bman
X
Comment by
a2bman
on May 22, 2024 8:32am
RE:RE:RE:RE:RE:RE:New and growing
Yea,. not enough of those and sitting on the bid isn't working that well either. This thing is rippin
(33)
•••
Speedmaster2022
X
Comment by
Speedmaster2022
on May 16, 2024 2:09pm
RE:RE:RE:RE:RE:New and growing
Me too...buying the dips
(998)
•••
a2bman
X
Comment by
a2bman
on May 07, 2024 2:53pm
RE:RE:RE:RE:New and growing
I like it. doesnt look like the MMs are going to let this drop too low. Good sign
(33)
•••
Speedmaster2022
X
Comment by
Speedmaster2022
on Apr 30, 2024 2:58pm
RE:RE:RE:New and growing
50 mil. Ish market cap $17 mil.
(998)
•••
a2bman
X
Comment by
a2bman
on Apr 30, 2024 12:03pm
RE:RE:New and growing
Yea me too, usually works out real well with these RTO's Ive been trying to get market cap numbers but I cant seem to find anything on sedar. Do you know how many shares out? It looks like
...more
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences